Rockwell Medical (NASDAQ:RMTI) Now Covered by Analysts at Rodman & Renshaw

Rodman & Renshaw started coverage on shares of Rockwell Medical (NASDAQ:RMTI) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $5.00 price objective on the stock.

A number of other research analysts have also recently weighed in on the stock. StockNews.com raised shares of Rockwell Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 13th. HC Wainwright reaffirmed a “buy” rating and set a $9.00 price target on shares of Rockwell Medical in a research report on Wednesday, September 11th.

Rockwell Medical Price Performance

RMTI opened at $2.36 on Thursday. The company’s 50 day simple moving average is $3.68 and its 200 day simple moving average is $2.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.60 and a current ratio of 2.41. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15. The stock has a market capitalization of $76.28 million, a PE ratio of -47.10 and a beta of 1.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Rockwell Medical by 4.0% during the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock valued at $1,856,000 after buying an additional 43,302 shares in the last quarter. Armistice Capital LLC lifted its position in shares of Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after purchasing an additional 592,000 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of Rockwell Medical by 877.1% during the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after purchasing an additional 92,189 shares in the last quarter. Beacon Financial Advisory LLC acquired a new position in shares of Rockwell Medical during the third quarter worth $98,000. Finally, Verus Capital Partners LLC acquired a new position in shares of Rockwell Medical during the third quarter worth $51,000. 23.31% of the stock is owned by institutional investors and hedge funds.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.